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Introduction: Detailed reporting of resection strategies (RS)
and resection techniques (RT) for tumor excision during partial
nephrectomy (PN) is lacking in the current literature. The aim
of the study was to evaluate (i) possible correlations between
patients’ and/or tumors’ characteristics and RT performed and
(ii) whether the type of RT does influence perioperative
outcomes after PN, harnessing the newly proposed Surface-
Intermediate-Base (SIB) margin score as a standardized
reporting system. Materials and Methods: After Institutional
Review Board’s approval, data were prospectively collected
from a cohort of 507 patients undergoing NSS at 16 high-
volume Centers across the U.S. and Europe over a 6-month
enrollment period. RT was classified according to the SIB
score. RS was classified as “enucleative”, “enucleoresective”
or “resective” according to the most prevalent RT performed
in each centre’s cohort. Descriptive and comparative analyses
were performed in the six enucleoresective RS centres (ERC).
Results: Overall, 507 patients were finally enrolled in the study.
The RT was classified as pure or hybrid enucleation (E, SIB 0-
2), pure or hybrid enucleoresection (ER, SIB 3-4) and resection
(R, SIB 5) in 266 (52.5%), 150 (29.6%) and 91(17.9%)
patients, respectively, in the overall cohort, while in 53
(33.1%), 83 (51.9%) and 24 (15.0%) patients in the ERC.
Demographic data, comorbidity scores, surgical indication and
approach and PADUA score did not significantly differ
between the E, ER and R groups in the ERC. Tumors >4.0 cm
were 21 (40.4%), 41 (49.4%) and 4 (16.7%) in the E, ER and
R groups (p=0.02), respectively. A clampless strategy was used
in 19.2%, 13.2% and 8.3% of patients (p>0.05). Median warm
ischemia time (WIT) was 19 (15-24), 17 (14-23) and 17 (15-
21) minutes in the E, ER and R groups (p>0.05). Surgical post-
operative complications were recorded in 7.5%, 13.2% and
4.2% of patients (p=0.05). Positive surgical margin rate was
7.0%, 13.4% and 0% of patients, respectively (p>0.05).
Trifecta outcome was achieved in 67.2%, 71.6% and 73.7% of
patients for the E, ER and R groups (p>0.05). Discussion and
Conclusions: This is the first study evaluating pre-operative
predictive factors of RTs performed during PN and whether the
type of RT significantly impacts on NSS outcomes using a
standardized instrument of reporting. Overall, in ERC, ER
represents less than 52%. ER and E are performed in a
significantly higher proportion of tumors >4 cm compared to
R. Relating to surgical outcomes, ER was associated with a
significantly higher rate of post-operative surgical complication
compared to E and R. However, Trifecta achievement was
comparable among the three techniques.
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Introduction/Aim: Resection methodology is rarely reported in
current nephron-sparing surgery (NSS) literature. Yet, a
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relationship between resection technique (RT) and
complication rates, preserved parenchymal volume, surgical
margins and oncologic outcomes likely exists. The aim of the
study was to evaluate the newly proposed Surface-
Intermediate-Base (SIB) margin score as a standardized
reporting system of RT in a cohort of patients undergoing NSS
at 16 high-volume Centers across the U.S. and Europe.
Materials and Methods: After Institutional Review Board’s
approval, data were prospectively collected over a 6-month
enrollment period. Results: A total of 507 patients were finally
enrolled in the study. The mean number of patients included
per center was 32 (range=11-90). A mix of open (150, 29.4%),
laparoscopic (67, 13.2%) and robotic (290, 57%) approaches
were harnessed for NSS. The median interquartile range (IQR)
of pre-operative tumor size for the entire cohort was 3.10 cm
(2.50-4.30). Based on the PADUA score, 195 (38.5%), 188
(37.1%) and 114 (22.5%) tumors were classified as low
(PADUA 6-7), moderate (PADUA 8-9) and high (PADUA 10-
13) complexity tumors, respectively. At pathological analysis,
30 (5.9%) positive surgical margins were recorded. Overall,
the Trifecta outcomes (defined as absence of perioperative
complications, negative surgical margins and warm ischemia
time (WIT)<25 min) were achieved in 370 (73%) of patients.
A snapshot of RTs performed in the entire cohort according
to the SIB margin score is presented in Figure 1. The overall
RT was classified as pure enucleation (SIB 0-1), hybrid
enucleation (SIB 2), pure enucleoresection (SIB 3), hybrid
enucleoresection (SIB 4) and resection (SIB 5) in 174
(34.3%), 92 (18.1%), 106 (20.9%), 44 (8.7%) and 91 (17.9%)
patients, respectively. Conclusion: Standardized reporting of
resection technique is lacking in the current NSS literature.
We recently introduced a standardized scoring system, the SIB
margin score, which quantitates the salient aspects of resection
approaches after PN through a visual analysis of the intrarenal
portion of the specimen immediately after surgery. Harnessing
this systematic characterization of renal mass RTs, in an
international multi-institutional cohort, we -for the first time-
demonstrated that resection approaches vary and renal tumor
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Figure 1. Snapshot of RTs performed in the entire cohort according to the SIB margin score is presented.
enucleation is employed quite frequently even at institutions
that do not support its ubiquitous use. These data lay the
groundwork for determining whether RT is a modifiable
variable for functional and oncologic outcomes in patients
who undergo NSS. 
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Aim: The aim of this study was to analyse the intra- and post-
operative complications, as well as the predictive factors of
Trifecta outcome in patients submitted to endoscopic robot-
assisted simple enucleation (ERASE) and open simple
enucleation (OSE) for clinical T1 renal masses. Materials and
Methods: Overall, 634 cases treated with OSE (n=290) and
ERASE (n=344) were prospectively recorded in our
Department between 2006 and 2014. Trifecta was defined as
simultaneous ischemia time <25 min, no surgical
complication and negative surgical margin. A univariate
analysis and multivariate logistic regression were performed
for Trifecta. Results: The two groups were comparable for
body mass index (BMI), comorbidity, tumor side, clinical T
score, tumor diameter, surgical indication, pre-operative renal
function, pre-operative hemoglobin and hematocrit. A
significant difference was found between the OSE and the
ERASE groups in operative time (115 (96-130) vs. 150 (120-
180) minutes, p<0.0001), pedicle clamping (93.8% vs.
69.2%, p<0.0001), estimated blood loss (EBL) (150 (100-
200) vs. 100 (100-143) cc, p<0.0001) and intraoperative
complications (3.4% vs. 1.7%, p=0.02). The two groups were
comparable for warm ischemia time (WIT) ≥25 min. A
significant difference was found between OSE and ERASE
in overall (16.6% vs. 5.5%, p<0.0001), Clavien 2 (11.7% vs.
4.4%, p=0.02) and Clavien 3 (3.1% vs. 1.7%, p=0.04) post-
operative surgical complications, length of stay (6.0 (5.0-7.0)
vs. 5.0 (4.0-6.0) days, p<0.0001), pre-operative 1st day delta
creatinine (0.3 (0.2-0.4) vs. 0.15 (0.1-0.2) mg/dl, p<0.0001),
positive surgical margins (2.1% vs. 1.5%, p=0.04), and
Trifecta achievement (73.8% vs. 85.5%, p<0.0001). At
univariate analysis, a higher median clinical diameter, a
higher mean age, a higher median Charlson comorbidity
index (CCI), endophytic tumor growth pattern, renal sinus
and calyceal dislocation of the tumor, a higher median
PADUA score and OSE were predictive factors of Trifecta
achievement. At multivariate analysis, CCI lost significance
(p=0.26), while age (odds ratio (OR)=1.02, 95% confidence
interval (95% CI)=1.00-1.04, p=0.001), clinical diameter
(OR=1.22, CI=1.05-1.42, p=0.008), PADUA score (OR=1.23,
CI=1.07-1.41, p=0.004) and OSE (OR=1.74, CI=1.13-2.68,
p=0.01) were confirmed predictive factors for Trifecta failure.
Conclusion: The ERASE is a feasible and safe technique,
which shows a comparable WIT, together with a significantly
lower EBL, surgical complications’ rate, length of stay and a
significantly higher Trifecta achievement compared to OSE.
Age, comorbidity, tumor diameter and PADUA score, in
association with surgical approach, represent significant
predictive factors of Trifecta failure.
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